what are some glp-1 drugs Do The Benefits of OutWeigh the Negatives? Patient education tips for GLP-1,

This updated strategy is tailored to address established cardiovascular disease, high cardiovascular risk, heart failure, kidney disease, or obesity [5, 6]

It is also important to consider the potential for interactions with chemotherapeutic agents

ChemBioChem 12, 25552559

Tang et al., 2020)

Consequently, the activation of AMPK can inhibit fatty acid synthesis and enhance the oxidation of free fatty acids by decreasing malonyl-CoA levels, thus mitigating its inhibitory effect on CPT1 activity

The STEP program trials with semaglutide (a GLP-1-only agonist) and the SURMOUNT trials with tirzepatide (dual GIP/GLP-1 agonist) represent the strongest weight loss efficacy data in the history of pharmacotherapy for obesity